Paper41322697
Advances in 3D bioprinting for modeling the blood-brain barrier in neurodegenerative diseases.
Tan S and 3 others. Front Mol Biosci, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Advances in 3D bioprinting for modeling the blood-brain barrier in neurodegenerative diseases. Papers, record 41322697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41322697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advances in 3D bioprinting for modeling the blood-brain barrier in neurodegenerative diseases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33357409 | The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells. | Immunity | 2021 | https://conductscience.org/library/papers/33357409 | PubMed |
| 2 | 37820611 | A 3D-printed blood-brain barrier model with tunable topology and cell-matrix interactions. | Biofabrication | 2023 | https://conductscience.org/library/papers/37820611 | PubMed |
| 3 | 36353359 | New insight into neurological degeneration: Inflammatory cytokines and blood-brain barrier. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/36353359 | PubMed |
| 4 | 35229856 | 3D or not 3D: a guide to assess cell viability in 3D cell systems. | Soft Matter | 2022 | https://conductscience.org/library/papers/35229856 | PubMed |
| 5 | 34867185 | Tight Junctions of the Neurovascular Unit. | Front Mol Neurosci | 2021 | https://conductscience.org/library/papers/34867185 | PubMed |
| 6 | 27141418 | Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking. | Tissue Barriers | 2016 | https://conductscience.org/library/papers/27141418 | PubMed |
| 7 | 22285429 | Photopolymerization of cell-encapsulating hydrogels: crosslinking efficiency versus cytotoxicity. | Acta Biomater | 2012 | https://conductscience.org/library/papers/22285429 | PubMed |
| 8 | 34894520 | Prevalence, risk and protective factors for mild cognitive impairment in a population-based study of Singaporean elderly. | J Psychiatr Res | 2022 | https://conductscience.org/library/papers/34894520 | PubMed |
| 9 | 33423792 | Blood-Brain Barrier Dynamics to Maintain Brain Homeostasis. | Trends Neurosci | 2021 | https://conductscience.org/library/papers/33423792 | PubMed |
| 10 | 33586666 | On-chip high-definition bioprinting of microvascular structures. | Biofabrication | 2021 | https://conductscience.org/library/papers/33586666 | PubMed |
| 11 | 31244605 | A Novel Transwell Blood Brain Barrier Model Using Primary Human Cells. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/31244605 | PubMed |
| 12 | 27658612 | Bioink properties before, during and after 3D bioprinting. | Biofabrication | 2016 | https://conductscience.org/library/papers/27658612 | PubMed |
| 13 | 37003488 | An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines. | Adv Drug Deliv Rev | 2023 | https://conductscience.org/library/papers/37003488 | PubMed |
| 14 | 36782313 | 3D In Vitro Blood-Brain-Barrier Model for Investigating Barrier Insults. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/36782313 | PubMed |
| 15 | 29322273 | The emerging influenza virus threat: status and new prospects for its therapy and control. | Arch Virol | 2018 | https://conductscience.org/library/papers/29322273 | PubMed |
| 16 | 36802199 | Advances in Gelatin Bioinks to Optimize Bioprinted Cell Functions. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/36802199 | PubMed |
| 17 | 29239532 | A 3D Real-Scale, Biomimetic, and Biohybrid Model of the Blood-Brain Barrier Fabricated through Two-Photon Lithography. | Small | 2018 | https://conductscience.org/library/papers/29239532 | PubMed |
| 18 | 25630899 | In Vitro Blood-Brain Barrier Models-An Overview of Established Models and New Microfluidic Approaches. | J Pharm Sci | 2015 | https://conductscience.org/library/papers/25630899 | PubMed |
| 19 | 36904106 | Polyphenols Mediate Neuroprotection in Cerebral Ischemic Stroke-An Update. | Nutrients | 2023 | https://conductscience.org/library/papers/36904106 | PubMed |
| 20 | 23749882 | Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis. | Anticancer Res | 2013 | https://conductscience.org/library/papers/23749882 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793082 | Construction and Applicability Scenarios of 3D Neurovascular Unit Models In Vitro. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793082 | PubMed |
| 42216436 | From Technological Innovation to Clinical Translation: Progress and Challenges in 3D Bioprinting for the Development of Breast Cancer Bone Metastasis Models. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42216436 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41322697
GET https://conductscience.org/api/papers/v1/41322697/references?page=2